Literature DB >> 11752697

Proteolytic processing of a human astrovirus nonstructural protein.

David Kiang1, Suzanne M Matsui1.   

Abstract

To analyse the activity of the putative 3C-like serine protease encoded in open reading frame (ORF)-1a of human astrovirus serotype 1 (HAstV-1), ORF-1a was transcribed and translated in vitro. Translation products, identified by immunoprecipitation with specific antibodies against recombinant C-terminal ORF-1a fragments, include the full-length 101 kDa (p101) protein and a 38 kDa band (p38). In addition, a 64 kDa protein (p64) was immunoprecipitated by an anti-FLAG antibody when a FLAG epitope was inserted at the N terminus of the ORF-1a product. Mutation of the amino acids predicted to form the catalytic triad of the HAstV-1 3C-like serine protease (Ser-551, Asp-489, His-461) resulted in undetectable levels of p38, supporting the involvement of the HAstV-1 3C-like serine protease and the importance of these amino acids in the processing of p101 into p38 and p64. N-terminal deletions of up to 420 aa of p101 that did not involve the predicted 3C-like serine protease motif did not alter levels of p38 compared to wild-type. C-terminal deletion analysis localized p38 to the C terminus of ORF-1a. Mutation of the P1 residue of the predicted cleavage site, which is conserved among known human and sheep astrovirus sequences, resulted in no detectable p38, supporting cleavage at the Gln-567/Thr-568 dipeptide. These results suggest that p101 is cleaved into an N-terminal p64 fragment and a C-terminal p38 product at Gln-567/Thr-568 in a process that is dependent on the viral 3C-like serine protease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752697     DOI: 10.1099/0022-1317-83-1-25

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Processing of nonstructural protein 1a of human astrovirus.

Authors:  Ute Geigenmüller; Teri Chew; Nancy Ginzton; Suzanne M Matsui
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Protein products of the open reading frames encoding nonstructural proteins of human astrovirus serotype 8.

Authors:  Ernesto Méndez; M P Elizabeth Salas-Ocampo; María Elena Munguía; Carlos F Arias
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  C-terminal nsP1a protein of human astrovirus colocalizes with the endoplasmic reticulum and viral RNA.

Authors:  Susana Guix; Santiago Caballero; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 4.  Identification of structural domains involved in astrovirus capsid biology.

Authors:  Neel K Krishna
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

Review 5.  Human astroviruses.

Authors:  Albert Bosch; Rosa M Pintó; Susana Guix
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  The C-terminal nsP1a protein of human astrovirus is a phosphoprotein that interacts with the viral polymerase.

Authors:  Cristina Fuentes; Susana Guix; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

7.  Characterization of Bafinivirus main protease autoprocessing activities.

Authors:  Rachel Ulferts; Thomas C Mettenleiter; John Ziebuhr
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

8.  Complete genome sequence of a highly divergent astrovirus isolated from a child with acute diarrhea.

Authors:  Stacy R Finkbeiner; Carl D Kirkwood; David Wang
Journal:  Virol J       Date:  2008-10-14       Impact factor: 4.099

9.  Vaccinia virus recombinant expressing an 87-kilodalton polyprotein that is sufficient to form astrovirus-like particles.

Authors:  Rosa M Dalton; Esperanza P Pastrana; Alicia Sánchez-Fauquier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Complete genome sequence of an astrovirus identified in a domestic rabbit (Oryctolagus cuniculus) with gastroenteritis.

Authors:  Mark D Stenglein; Eric Velazquez; Cheryl Greenacre; Rebecca P Wilkes; J Graham Ruby; Julia S Lankton; Donald Ganem; Melissa A Kennedy; Joseph L DeRisi
Journal:  Virol J       Date:  2012-09-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.